Testing an Immune Cell Treatment Made From a Person's Own Brain Tumor
Original title: Study of GC101 TIL in Brain Glioma (Soochow2)
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early first test in people, so no one knows yet if it is safe or if it works.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial is testing a treatment that uses immune cells taken from a person's own glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary.
Who this trial is for. This trial is for people with malignant glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, a fast growing brain tumor. Doctors take immune cells called TILs out of tumor tissue removed during surgery. They grow more of those cells in a lab. Then they give the cells back to the person through a vein, after medicines that lower the immune system first.
Where it stands. This trial has not reported results. The team is looking at how safe the treatment is and whether it helps. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: This is an early look at a new idea for treating malignant glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary. Someone who fits the type of tumor being studied could ask their care team whether a trial like this is worth looking into.
What it doesn't mean: This does not mean there is a new treatment you can get. A trial is a test, not proven care. Being in a trial is not a guarantee that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, August 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.